Efficacy of Acapella on Spirometry Measures in Patients With Bronchiectasis
NCT ID: NCT05838144
Last Updated: 2023-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2023-08-01
2023-10-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. Only routine physical therapy program group ( control group). Will only take medications and routine chest physical therapy program.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acapella Versus Lung Flute in Treatment of COPD Patients the Study Aims to Identify the Preference Between the Two Devices According to Treatment of COPD Patients Regarding Pulmonary Function Tests , Exercise Tolerence and Quality of Life Questionnaire,
NCT06801106
Short-and Long-term Effects of a Home-based Rehabilitation Program in Patients With Bronchiectasis
NCT02731482
Effect of Aerobic Exercises Versus Incentive Spirometer Device on Post-covid Pulmonary Fibrosis Patients
NCT06191367
Acute Effects of a Flutter Device and Chest Wall Compression on Respiratory System Impedance in Bronchiectasis Patients
NCT02509637
Is Regular Chest Physiotherapy an Effective Treatment in Severe, Non Cystic Fibrosis Bronchiectasis?
NCT00816309
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Only routine physical therapy program group( control group). Will only take medications and routine chest physical therapy program Spirometer measures such as forced vital capacity (FVC) and forced expiratory volume in the first second (FEV1) will be measured for every patient before and after the end of 7 days.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acapella
Will use Acapella device 3 times per day for 15 minutes for 7 days beside medications and routine physical therapy program.
Acapella device
Group A. Will use Acapella device.
Only routine chest physical therapy program
Group B. Will take medications and perform routine chest physical therapy program.
Only routine physical therapy program
Only they will receive medications and routine physical therapy program.
Only routine chest physical therapy program
Group B. Will take medications and perform routine chest physical therapy program.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acapella device
Group A. Will use Acapella device.
Only routine chest physical therapy program
Group B. Will take medications and perform routine chest physical therapy program.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age range between 40 to 55 years old of both gender.
3. Cooperative patients.
Exclusion Criteria
2. Un controlled hypertensive patients.
3. Un controlled diabetic patients.
40 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
South Valley University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shymaa yussuf abo zaid
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shymaa Y Abo zaid
Role: PRINCIPAL_INVESTIGATOR
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shymaa yussuf abo zaid
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PT-IMG-02/2023-505
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.